rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2011-6-17
|
pubmed:abstractText |
The functional plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism has previously been associated with hypertension. In recent years, central blood pressure, rather than brachial has been argued a better measure of cardiovascular damage and clinical outcome. The aim of this study was to investigate the possible influence of the 4G/5G polymorphism on central arterial blood pressure in a cohort of elderly individuals.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1941-7225
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
802-8
|
pubmed:meshHeading |
pubmed-meshheading:21490692-Aged,
pubmed-meshheading:21490692-Aged, 80 and over,
pubmed-meshheading:21490692-Blood Pressure,
pubmed-meshheading:21490692-Cohort Studies,
pubmed-meshheading:21490692-Female,
pubmed-meshheading:21490692-Follow-Up Studies,
pubmed-meshheading:21490692-Genetic Predisposition to Disease,
pubmed-meshheading:21490692-Genotype,
pubmed-meshheading:21490692-Humans,
pubmed-meshheading:21490692-Hypertension,
pubmed-meshheading:21490692-Male,
pubmed-meshheading:21490692-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:21490692-Polymorphism, Genetic,
pubmed-meshheading:21490692-Risk Factors,
pubmed-meshheading:21490692-Sex Characteristics,
pubmed-meshheading:21490692-Sweden
|
pubmed:year |
2011
|
pubmed:articleTitle |
Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure.
|
pubmed:affiliation |
Division of Cardiovascular Medicine, Department of Medical and Health Sciences, Faculty of Health Sciences, Linköping University, Linköping, Sweden. hanna.bjorck@liu.se
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|